Development of aortic valve sclerosis or stenosis in rabbits: Role of cholesterol and calcium

Journal of Heart Valve Disease

Volumn 17, Issue 4, 2008, Pages 381-387

  Drolet, Marie Claude ^a   Couet, Jaques ^a   Arsenault, Marie ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALCIUM; CHOLESTEROL; ERGOCALCIFEROL; PHOSPHATE; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE DISEASE; AORTA VALVE SCLEROSIS; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE MARKER; ECHOCARDIOGRAPHY; FOLLOW UP; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE; VITAMIN SUPPLEMENTATION;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCIUM; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ERGOCALCIFEROLS; HYPERCHOLESTEROLEMIA; MALE; PHOSPHATES; RABBITS; SCLEROSIS;

EID: 50249161499     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. O'Keefe JH, Jr., Lavie CJ, Nishimura RA et al. Degenerative aortic stenosis. One effect of the graying of America. Postgrad Med. 1991;89:143-144
2. Adler Y, Levinger U, Koren A et al. Relation of nonobstructive aortic valve calcium to carotid arterial atherosclerosis. Am J Cardiol. 2000;86:1102-1105
3. Branch KR, O'Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep. 2002;4:111-117
4. Demer LL. A skeleton in the atherosclerosis closet. Circulation. 1995;92:2029-2032
5. Kaden JJ, Haase KK, Borggrefe M. [Calcific aortic valve stenosis: degeneration or atherosclerosis?]. Dtsch Med Wochenschr. 2001;126:405-407
6. Mohler ER, Sheridan MJ, Nichols R et al. Development and progression of aortic valve stenosis: atherosclerosis risk factors - a causal relationship? A clinical morphologic study. Clin Cardiol. 1991;14:995-999
7. Kamimura R, Suzuki S, Sakamoto H et al. Development of atherosclerotic lesions in cholesterol-loaded rabbits. Exp Anim. 1999;48:1-7
8. Wierzbicki A, Shetty C. Aortic stenosis: an atherosclerotic disease? J Heart Valve Dis. 1999;8:416-423
9. Antia AU, Wiltse HE, Rowe RD et al. Pathogenesis of the supravalvular aortic stenosis syndrome. J Pediatr. 1967;71:431-441
10. Ortlepp JR, Hoffmann R, Ohme F et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85:635-638
11. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. 2003;41:1211-1217
12. Adler Y, Levinger U, Koren A et al. Relation of nonobstructive aortic valve calcium to carotid arterial atherosclerosis. Am J Cardiol. 2000;86:1102-1105
13. Branch KR, O'Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep. 2002;4:111-117
14. Delaye J, Chevalier P, Delahaye F et al. Valvular aortic stenosis and coronary atherosclerosis: pathophysiology and clinical consequences. Eur Heart J. 1988;9 Suppl E:83-86
15. Demer LL. A skeleton in the atherosclerosis closet. Circulation. 1995;92:2029-2032
16. Lacy J, Goodin R, McMartin D et al. Coronary atherosclerosis in valvular heart disease. Ann Thorac Surg. 1977;23:429-435
17. Mohler ER, Sheridan MJ, Nichols R et al. Development and progression of aortic valve stenosis: atherosclerosis risk factors - a causal relationship? A clinical morphologic study Clin Cardiol. 1991;14:995-999
18. Nakib A, Lillehei CW, Edwards JE. The degree of coronary atherosclerosis in aortic valvular disease. Arch Pathol. 1965;80:517-520
19. Passoni F, D'Urbano M, Aiazzi L et al. [Aortic valve disease and coronary atherosclerosis. Clinical and coronarographic study (author's transl)]. G Ital Cardiol. 1981-11:1399-1404
20. Vekshtein VI, Alexander RW, Yeung AC et al. Coronary atherosclerosis is associated with left ventricular dysfunction and dilatation in aortic stenosis. Circulation. 1990;82:2068-2074
21. Acar J, Michel PL, de Gevigney G. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?]. Presse Med. 2000;29:1867-1875
22. Aronow WS, Ahn C, Kronzon I et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693-695
23. Bahler RC, Desser DR, Finkelhor RS et al. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999;84:1044-1048
24. Boon NA, Bloomfield P. The medical management of valvar heart disease. Heart. 2002;87:395-400
25. Branch KR, O'Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep. 2002;4:111-117
26. Choudhury RP, Leyva F. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2001;103:E67
27. Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis. 1984;37:407-415
28. Iivanainen AM, Lindroos M, Tilvis R et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol. 1996;78:97-101
29. Iivanainen AM, Lindroos M, Tilvis R et al. Calcific degeneration of the aortic valve in old age: is the development of flow obstruction predictable? J Intern Med. 1996;239:269-273
30. Kennedy KD, Nishimura RA, Holmes DR, Jr. et al. Natural history of moderate aortic stenosis. J Am Coll Cardiol. 1991;17:313-319
31. Lindroos M, Kupari M, Valvanne J et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994;15:865-870
32. Lund O, Flo C, Jensen FT et al. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J. 1997;18: 1977-1987
33. Thulin LI, Sjogren JL. Aortic valve replacement with and without concomitant coronary artery bypass surgery in the elderly: risk factors related to long-term survival. Croat Med J. 2000;41:406-409
34. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. 2003;41:1211-1217
35. Kennedy JH, Henrion D, Wassef M et al. Osteopontin expression and calcium content in human aortic valves. J Thorac Cardiovasc Surg. 2000;120:427
36. O'Brien KD, Kuusisto J, Reichenbach DD et al. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995;92:2163-2168
37. Babaei S, Stewart DJ, Picard P et al. Effects of VasoCare therapy on the initiation and progression of atherosclerosis. Atherosclerosis. 2002;162:45-53
38. Otto CM, Kuusisto J, Reichenbach DD et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochernical studies. Circulation. 1994;90:844-853
39. Olsson M, Rosenqvist M, Nilsson J. Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol. 1994;24:1664-1671
40. Olsson M, Dalsgaard CJ, Haegerstrand A et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23:1162-1170
41. Otto CM, Kuusisto J, Reichenbach DD et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844-853
42. Maher ER, Young G, Smyth-Walsh B, et al. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet, 1987;2:875-877
43. Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci. 2003;325:237-24